fenofibrate has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chicaud, P; Debry, G; Demange, J; Drouin, P | 1 |
| Abdel Kawy, HS; El-Aziz, LF; El-Kharashi, OA; El-Samad, AA; Elmelegy, AA; Mohamed, DI | 1 |
2 other study(ies) available for fenofibrate and concanavalin a
| Article | Year |
|---|---|
Application of the concanavalin A precipitation technique in an evaluation of fenofibrate action on cholesterolemia in IIa and IIb hyperlipemic subjects.
Topics: Adult; Aged; Aging; Anticholesteremic Agents; Chemical Precipitation; Cholesterol; Concanavalin A; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Propionates; Sex Factors | 1983 |
Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Concanavalin A; Fenofibrate; Hepatitis; Liver; Male; Malondialdehyde; Oxidative Stress; Portal Pressure; PPAR alpha; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2013 |